Vir Biotechnology Inc (VIR)
7.635
-0.40
(-5.04%)
USD |
NASDAQ |
Apr 25, 16:00
7.60
-0.04
(-0.46%)
After-Hours: 20:00
Vir Biotechnology Total Assets (Quarterly): 1.919B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.919B |
| September 30, 2023 | 2.045B |
| June 30, 2023 | 2.244B |
| March 31, 2023 | 2.666B |
| December 31, 2022 | 2.802B |
| September 30, 2022 | 2.696B |
| June 30, 2022 | 2.619B |
| March 31, 2022 | 2.887B |
| December 31, 2021 | 1.954B |
| September 30, 2021 | 1.210B |
| Date | Value |
|---|---|
| June 30, 2021 | 1.058B |
| March 31, 2021 | 1.136B |
| December 31, 2020 | 918.76M |
| September 30, 2020 | 943.26M |
| June 30, 2020 | 672.24M |
| March 31, 2020 | 477.11M |
| December 31, 2019 | 512.07M |
| September 30, 2019 | 422.64M |
| June 30, 2019 | 456.85M |
| December 31, 2018 | 191.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
422.64M
Minimum
Sep 2019
2.887B
Maximum
Mar 2022
1.560B
Average
1.210B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 22.73B |
| Vistagen Therapeutics Inc | 131.07M |
| Immuneering Corp | 102.58M |
| SeaStar Medical Holding Corp | 3.513M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 328.82M |
| Shareholders Equity (Quarterly) | 1.590B |
| Current Ratio | 9.054 |